2-Phenyl-7-methylpyrazol<1,5-a>-pyrimidin-6-carbonsaeure | 71509-26-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-Phenyl-7-methylpyrazol<1,5-a>-pyrimidin-6-carbonsaeure
• 英文别名: 7-methyl-2-phenylpyrazolo[1,5-a]pyrimidine-6-carboxylic acid
• CAS: 71509-26-7
• 化学式: C₁₄H₁₁N₃O₂
• 分子量: 253.26
• InChiKey: XAOCDVHYGFKEQR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  67.5
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-Phenyl-7-methylpyrazol<1,5-a>-pyrimidin-6-carbonsaeure 生成 7-methyl-2-phenylpyrazolo[1,5-a]pyrimidine
  参考文献：
  名称：

  AUZZI G.; CECCHI L.; COSTANZO A.; PECORI VETTORI L.; BRUNI F.; PIRISINO R+, FARMACO. ED. SCI., 1979, 34, NO 6, 478-485

  摘要：

  DOI：
• 作为产物：
  描述：

  7-甲基-2-苯基吡唑并[1,5-a]嘧啶-6-羧酸乙酯 在 sodium hydroxide 、 乙醇 、 水 作用下， 反应 1.0h， 生成 2-Phenyl-7-methylpyrazol<1,5-a>-pyrimidin-6-carbonsaeure
  参考文献：
  名称：

  Cyanopyrrolidines useful for the treatment of inter alia metabolic syndrome

  摘要：

  公开号：

  EP1595866B1

文献信息

• Compound inhibiting dipeptidyl peptidase IV
  申请人：Kakigami Takuji

  公开号：US20060229286A1

  公开（公告）日：2006-10-12

  A dipeptidyl peptidase IV inhibitor which is satisfactory in respect of activity, stability and safety and has an excellent action as a pharmaceutical agent. A compound represented by the following general formula or a pharmaceutically acceptable salt thereof: wherein R 1 and R 2 each represents hydrogen, an optionally substituted C1-6 alkyl group, or —COOR 5 whereupon R 5 represents hydrogen or an optionally substituted C1-6 alkyl group, or R 1 , R 2 , and a carbon atom together represent a 3- to 6-membered cycloalkyl group, R 3 represents hydrogen or an optionally substituted C6-10 aryl group, R 4 represents a hydrogen or a cyano group, D represents —CONR 6 —, —CO— or —NR 6 CO—, R 6 represents hydrogen or an optionally substituted C1-6 alkyl group, E represents —(CH 2 ) m — whereupon m is 1 to 3, —CH 2 OCH 2 —, or —SCH 2 —, n is 0 to 3, and A represents an optionally substituted bicyclic heterocyclic group or bicyclic hydrocarbon group.

  一种二肽基肽酶IV抑制剂，具有活性、稳定性和安全性方面的满意度，并且作为药物剂量具有优异的作用。该化合物由以下通式表示或其药学上可接受的盐：其中R1和R2分别表示氢、可选取代的C1-6烷基或-COOR5，其中R5表示氢或可选取代的C1-6烷基，或者R1、R2和一个碳原子共同表示3-6个成员的环烷基，R3表示氢或可选取代的C6-10芳基，R4表示氢或氰基，D表示-CONR6-、-CO-或-NR6CO-，R6表示氢或可选取代的C1-6烷基，E表示-(CH2)m-，其中m为1至3，- O -或-S -，n为0至3，A表示可选取代的双环杂环基或双环烃基。
• COMPOUND INHIBITING DIPEPTIDYL PEPTIDASE IV
  申请人：SANWA KAGAKU KENKYUSHO CO., LTD.

  公开号：EP1595866A1

  公开（公告）日：2005-11-16

  The invention aims to provide a dipeptidyl peptidase IV inhibitor which is satisfactory in respect of activity, stability and safety and has an excellent action as a pharmaceutical agent. The invention is directed to a compound represented by the following general formula or a pharmaceutically acceptable salt thereof: wherein R1 and R2 each represents hydrogen, an optionally substituted C1-6 alkyl group, or -COOR5 whereupon R5 represents hydrogen or an optionally substituted C1-6 alkyl group, or R1 and R2, together with a carbon atom to which they are bound, represent a 3- to 6-membered cycloalkyl group, R3 represents hydrogen or an optionally substituted C6-10 aryl group, R4 represents a hydrogen or a cyano group, D represents -CONR6-, -CO- or -NR6CO-, R6 represents hydrogen or an optionally substituted C1-6 alkyl group, E represents -(CH2)m- whereupon m is an integer of 1 to 3, -CH2OCH2-, or -SCH2-, n is an integer of 0 to 3, and A represents an optionally substituted bicyclic heterocyclic group or bicyclic hydrocarbon group.

  本发明旨在提供一种二肽基肽酶 IV 抑制剂，该抑制剂在活性、稳定性和安全性方面都令人满意，并且作为药剂具有出色的作用。本发明涉及由以下通式代表的化合物或其药学上可接受的盐： 其中 R1 和 R2 各自代表氢、任选取代的 C1-6 烷基或 -COOR5 其中 R5 代表氢或任选取代的 C1-6 烷基，或 R1 和 R2 与它们结合的碳原子一起代表 3 至 6 元环烷基，R3 代表氢或任选取代的 C6-10 芳基、R4代表氢或氰基，D代表-CONR6-、-CO-或-NR6CO-，R6代表氢或任选取代的C1-6烷基，E代表-(CH2)m-，其中m为1至3的整数，- O -或-S -，n为0至3的整数，A代表任选取代的双环杂环基团或双环烃基团。
• Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor
  作者：Noriyasu Kato、Mitsuru Oka、Takayo Murase、Masahiro Yoshida、Masao Sakairi、Satoko Yamashita、Yoshika Yasuda、Aya Yoshikawa、Yuuji Hayashi、Mitsuhiro Makino、Motohiro Takeda、Yakufu Mirensha、Takuji Kakigami

  DOI：10.1016/j.bmc.2011.09.043

  日期：2011.12

  In the course of our program for discovery of novel DPP-IV inhibitors, a series of pyrazolo[1,5-a]pyrimidines were found to be novel DPP-IV inhibitors. We identified N-[2-(2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (4a) and described its pharmacological profiles. (C) 2011 Elsevier Ltd. All rights reserved.
• AUZZI G.; CECCHI L.; COSTANZO A.; PECORI VETTORI L.; BRUNI F., FARMACO. ED. SCI., 1979, 34, NO 9, 743-750
  作者：AUZZI G.、 CECCHI L.、 COSTANZO A.、 PECORI VETTORI L.、 BRUNI F.

  DOI：——

  日期：——
• TREATING CANCER
  申请人：Agency for Science, Technology and Research

  公开号：EP2908843B1

  公开（公告）日：2019-09-04